Communication - IIS Aragón

October 3, 2024
Posted by Communication - IIS Aragón el October 3, 2024
Categories

The Molecular Oncology group project of the IIS Aragón will receive funds from the Monzón Women's Race

On September 27, Alberto Jiménez Schuhmacher, principal investigator of the group, presented "High-precision missiles against tumors", a project that will be funded with the proceeds from the XNUMXth edition of the Monzón Women's Race.
Do you like it?
Read more
October 3, 2024
Posted by Communication - IIS Aragón el October 3, 2024
Categories

A prestigious journal publishes one of the latest research projects of the Precision Medicine in Respiratory Diseases (PRES) group of the IIS Aragón

Researchers at the IIS Aragón have published a study in the journal 'Archivos de Bronconeumología' which suggests that heart rate variation during apnea episodes may be a new biomarker of cardiovascular risk.
Do you like it?
Read more
October 2, 2024
Posted by Communication - IIS Aragón el October 2, 2024
Categories

The IIS Aragón participates in the conference 'The HRS4R seal in Aragon: strategy, evaluation and future'

On Monday 30th, the IIS Aragón and other institutions met at the Auditorium of the University of Zaragoza to share experiences and progress on the HR Excellence in Research Seal.
Do you like it?
Read more
October 1, 2024
Posted by Communication - IIS Aragón el October 1, 2024
Categories

The IIS Aragón participates in the European Researchers' Night

Last Friday, September 27, science took to the streets of Aragon with more than 250 scientists and 70 activities of all kinds. In Zaragoza, the research groups in primary care and mental health of the IIS Aragon collaborated.
Do you like it?
Read more
September 27, 2024
Posted by Communication - IIS Aragón el September 27, 2024
Categories

New early changes identified in the brains of people at risk for Alzheimer's

Analysis of brain activity and a specific marker in the blood can help detect these early alterations in individuals without symptoms. The study included 76 participants without cognitive impairment, of whom 54 had a family history of the disease.
Do you like it?
Read more
123456789101112131415161718192021222324252627282930313233343536373839404142